"The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) reviewed the emergency use authorisation (EUA) application for the second time on Monday and after detailed deliberation recommended granting emergency use authorisation to Covovax and COREBEVAX," an official source said.
https://ift.tt/eA8V8J
https://ift.tt/eA8V8J
Comments
Post a Comment